HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance

被引：0
作者：
Shih-Chiang Huang
Kwai-Fong Ng
Shang-En Lee
Kuang-Hua Chen
Ta-Sen Yeh
Tse-Ching Chen
机构：
[1] Chang Gung University,Department of Anatomical Pathology, Chang Gung Memorial Hospital
[2] College of Medicine,Cancer Diagnostic Laboratory
[3] Chang Gung Memorial Hospital,Department of Surgery, Chang Gung Memorial Hospital
[4] Chang Gung University,Department of Pathology
[5] College of Medicine,undefined
[6] Chang Gung Memorial Hospital,undefined
来源：
Gastric Cancer | 2016年 / 19卷
关键词：
Gastric cancer; HER2; Biopsy; Excision; Discordance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：176 / 182
页数：6
相关论文
共 50 条
  • [41] Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer (vol 22, pg 518, 2019)
    Yagi, Shusuke
    Wakatsuki, Takeru
    Yamamoto, Noriko
    Chin, Keisho
    Takahari, Daisuke
    Ogura, Mariko
    Ichimura, Takashi
    Nakayama, Izuma
    Osumi, Hiroki
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Fujisaki, Junko
    Ishikawa, Yuichi
    Yamaguchi, Kensei
    Namikawa, Ken
    Horiuchi, Yusuke
    GASTRIC CANCER, 2019, 22 (03) : 526 - 526
  • [42] Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma? Discordant HER2 Status of Paired Endometrial Biopsy and Hysterectomy Specimens in the Presence of Frequent Intratumoral Heterogeneity
    Rottmann, Douglas
    Assem, Hisham
    Matsumoto, Nana
    Wong, Serena
    Hui, Pei
    Buza, Natalia
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (03) : 263 - 271
  • [43] Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Sanchez Lorenzo, Maria Luisa
    Gallego Plazas, Javier
    Custodio, Ana
    Hernandez, Raquel
    Garrido, Marcelo
    Garcia, Teresa
    Echavarria, Isabel
    Maria Cano, Juana
    Rodriguez Palomo, Alberto
    Mangas, Monserrat
    Macias Declara, Ismael
    Ramchandani, Avinash
    Visa, Laura
    Viudez, Antonio
    Buxo, Elvira
    Diaz-Serrano, Asuncin
    Lopez, Carlos
    Azkarate, Aitor
    Longo, Federico
    Castanon, Eduardo
    Sanchez Bayona, Rodrigo
    Pimentel, Paola
    Luisa Limon, Maria
    Cerda, Paula
    Alvarez Llosa, Renata
    Serrano, Raquel
    Felices Lobera, Maria Pilar
    Alsina, Maria
    Hurtado Nuno, Alicia
    Gomez-Martin, Carlos
    GASTRIC CANCER, 2017, 20 (03) : 465 - 474
  • [44] HER2 testing in gastric cancer: results of a German expert meeting
    Florian Lordick
    Salah-Eddin Al-Batran
    Manfred Dietel
    Timo Gaiser
    Ralf-Dieter Hofheinz
    Thomas Kirchner
    Hans H. Kreipe
    Sylvie Lorenzen
    Markus Möhler
    Alexander Quaas
    Christoph Röcken
    Josef Rüschoff
    Andrea Tannapfel
    Peter Thuss-Patience
    Gustavo Baretton
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 835 - 841
  • [45] Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
    Naoyuki Tominaga
    Takuji Gotoda
    Megumi Hara
    Matthew D. Hale
    Takayoshi Tsuchiya
    Jun Matsubayashi
    Shin Kono
    Chika Kusano
    Takao Itoi
    Kazuma Fujimoto
    Fuminori Moriyasu
    Heike I. Grabsch
    Gastric Cancer, 2016, 19 : 553 - 560
  • [46] Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance
    Yu, Guan Zhen
    Chen, Ying
    Wang, Jie Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1331 - 1339
  • [47] HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery
    Grenda, Anna
    Wojas-Krawczyk, Kamila
    Skoczylas, Tomasz
    Krawczyk, Pawel
    Sierocinska-Sawa, Jadwiga
    Wallner, Grzegorz
    Milanowski, Janusz
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [48] The risk of weekend biopsy: Impact of specimen source and fixation status on HER2 assessment in the treatment of advanced gastric cancer (The HER_WEEKEND study)
    Nakamura, Michio
    Watanabe, Ayako
    Yoshizawa, Aki
    Iwasaki, Sari
    Nomura, Asako
    Matsumura, Mariko
    Murai, Taichi
    Itaya, Kazufumi
    Koike, Yuta
    Izumi, Takaaki
    Endo, Ayana
    Kato, Shin
    Ono, Yuji
    Ohshima, Takahiro
    Okazaki, Nanase
    Nakagawa, Shimpei
    Ishii, Yasushi
    Fukasawa, Yuichiro
    Yokota, Isao
    Tsuji, Takahiro
    Nishikawa, Shuji
    PATHOLOGY INTERNATIONAL, 2023, 73 (10) : 509 - 519
  • [49] Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia
    Rajadurai P.
    Fatt H.K.
    Ching F.Y.
    Journal of Gastrointestinal Cancer, 2018, 49 (2) : 150 - 157
  • [50] Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HEr2 status of the whole tumor
    Mueller-Holzner, E
    Fink, V
    Frede, T
    Marth, C
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 13 - 19
12345